CVT-301

levodopa inhalation powder · Acorda Therapeutics

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for CVT-301, covering 2016-07-14 to 2019-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes [Phase 3]